Cycad Group

Total investments

28

Average round size

18M

Portfolio companies

16

Follow on index

0.43

Exits

6

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
AutomotiveBiotechnologyHealth CareHealth DiagnosticsManufacturingMedicalLife SciencePharmaceuticalTherapeuticsClinical Trials

Summary

The main office of represented VC is situated in the Santa Barbara. The fund was located in North America if to be more exact in United States.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Cycad Group, startups are often financed by Polaris Partners, Lux Capital, Flagship Pioneering. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, SR One, Lux Capital. In the next rounds fund is usually obtained by Polaris Partners, Skyline Ventures, SR One.

The overall number of key employees were 1.

Considering the real fund results, this VC is 15 percentage points less often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. This Cycad Group works on 11 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2012. The increased amount of exits for fund were in 2018. The fund is constantly included in less than 2 deals per year.

We can highlight the next thriving fund investment areas, such as Energy, Solar. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Catalytic Solutions, OvaScience, SOFIE. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Show more

Investments analytics

Analytics

Total investments
28
Lead investments
0
Exits
6
Follow on index
0.43
Investments by industry
  • Biotechnology (16)
  • Health Diagnostics (7)
  • Health Care (7)
  • Clinical Trials (6)
  • Medical (6)
  • Show 22 more
Investments by region
  • United States (28)
Peak activity year
2012

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
26M
Group Appearance index
0.86
Avg. company exit year
9
Avg. multiplicator
1.63

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Catalytic Solutions 10 Jan 2002 Automotive, Manufacturing, Energy Efficiency Late Stage Venture 30M United States, California, Oxnard
CranioVation 02 May 2018 Biotechnology, Health Diagnostics, Innovation Management Seed 642K United States, Minnesota, Minneapolis
Lixivia 01 Jan 2021 Chemical, Industrial, Mining, Precious Metals Seed United States, California, Santa Barbara

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.